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                                         ABSTRACT
INTRODUCTION
Diabetes Mellitus, being a  major risk factor for cardiovascular disease 
is associated with myocardial infarction (MI)  and sudden death at a higher 
level. In diabetic patients, morbidity and mortality are higher following MI 
than non-diabetic subjects, with one-year mortality as equal to 50%. The rate 
of re-infarction is also higher. Diabetes has its impact on the short term as 
well as long term morbidity of myocardial infarction patients.
Platelet activation is enhanced; Diabetes is associated with a 
procoagulant state.  The likelihood of thrombotic events is increased. 
Thrombus propagation is encouraged; the efficacy of thrombolytic drugs is 
impaired . The chance of re-occlusion is also increased.
Measures which are simple as well as inexpensive are needed to assess 
the thrombolytic efficacy both in clinical practice as well as  in clinical trials . 
Several studies have shown the utility of ST segment monitoring as a simple 
and rapid means of assessing reperfusion status in patients receiving 
fibrinolytic therapy for acute ST elevation myocardial infarction.
2It is necessary to achieve successful recanalization of the epicardial 
vessel but microvascular flow strongly correlates with outcome. ST-segment 
changes are better than coronary angiogram in assessing myocardial 
perfusion.
AIMS AND OBJECTIVES :
To study the thrombolytic effect of streptokinase infusion between 
diabetic and non-diabetic  myocardial infarction patients with ECG as a tool.
MATERIALS AND METHODS
SELECTION OF STUDY POPULATION:
This study is to be conducted among patients , admitted in coronary 
care unit with the diagnosis of ST elevation myocardial infarction.
STUDY POPULATION:
100 patients 
STUDY PROTOCOL:
Patients who are diagnosed with ST elevation myocardial infarction are 
included in the study. Random blood sugar values are obtained on admission.
Electrocardiogram is obtained on admission and 90 min after streptokinase 
infusion. 
3Fasting and post prandial glucose values are recorded from all patients , 
in the morning of day following admission, or once the patients are stable.
The results are then analysed.
RESULTS:
On comparing the ST segment resolution among Diabetic and 
non-diabetic myocardial infarction patients , by using Chi square test, it is 
found that failed thrombolysis (<30% resolution ) is more in diabetics than 
non-diabetics ( p value is 0.004) which is significant whereas successful 
thrombolysis (>70% resolution) is more in non-diabetics than diabetics ( p 
value is 0.020; significant).
In diabetic MI patients( n=60), the number of people with 
successful thrombolysis( >70% ST resolution ) is 11 (18%), whereas failed 
thrombolysis ( < 30% ST resolution ) is 40 (67%). p value is 0.001, which is 
significant.
In non-diabetic MI patients (n=40), the number of people with 
successful thrombolysis ( >70% ST resolution) is 21 (52%), whereas failed 
thrombolysis ( <30% ST resolution ) is 7 ( 17.5%) . p value is 0.038 which is 
also significant.
4CONCLUSION:
On comparing the thrombolytic effect of Streptokinase  , it is observed  
that failed thrombolysis (< 30% ST resolution )  is more in diabetic STEMI  
patients when compared to non-diabetic STEMI patients. Successful 
thrombolysis (>70% ST resolution ) is more in non-diabetic than diabetic 
STEMI patients. 
Among diabetics, failed thrombolysis ( 67%) is more than successful 
thrombolysis ( 18%). Among non-diabetics, successful thrombolysis (52.5%) 
is more than failed thrombolysis ( 17.5%).
So, the outcome of thrombolysis of  acute ST elevation myocardial 
infarction patients is affected by type 2 diabetes mellitus .
Key words: Diabetes mellitus, STEMI, myocardial infarction, thrombolysis, 
electrocardiogram.
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changes are better than coronary angiogram in assessing myocardial 
perfusion. 
  This study is being done to compare the efficacy of thrombolytic drug, 
Streptokinase between diabetic and non-diabetic acute myocardial infarction 
patients using ST segment resolution in ECG as a simple tool. 
 Zairis et al conducted a study which concluded that even though 
diabetic patients receive prompt thrombolysis, the outcome is not as good as 
in non diabetics who receive thrombolytic therapy for acute myocardial 
infarction. Left ventricular function after thrombolysis is impaired in 
diabetics.  
 Acute coronary events are nowadays , more common in general 
population because the risk factors causing such events are on the increasing 
verge. Without prompt treatment , either in the form of fibrinolysis or 
percutaneous coronary intervention, the mortality as well as morbidity is very 
high. In golden hour for reperfusion therapy , that is the initial 1-1.5 hours is 
very important because myocardial tissues before they die have to be salvaged 
since death is irreversible.  
Also, the surrounding viable cells will also be in a state of ischemia and 
injury. In order to save these also, effective treatment is needed at the earliest 
possible time.    
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Streptokinase , the first thrombolytic drug discovered , although is 
associated with some allergic reactions and to some complications like 
hemorrhage and hypotension, is readily available and cost- effective also. A 
lot of newer thrombolytic drugs have come after streptokinase.  
ECG, being a simple and readily available tool is cost effective as well. 
The diagnosis of acute myocardial infarction is made on presentation of the 
patient in emergency room with the classical history of angina and ECG.  
 ST segment elevation is a marker of myocardial injury ; T wave is a 
marker of ischemia . After prompt thrombolysis, the elevated ST segment 
returns towards baseline. This can be identified by serial ECG monitoring. 
ECG taken at 90 minutes after thrombolysis is a reliable indicator of the effect 
of thrombolytic drug. This percentage of ST resolution correlates with the 
success of thrombolytic therapy. In our study, the effect of diabetes on the ST 
segment resolution is compared with non diabetics. 
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REVIEW OF LITERATURE 
 
Diabetes is an independent risk factor for coronary heart disease. Death 
from cardiovascular causes is 3 times more in men with Diabetes than without 
it. The risk of death in acute myocardial infarction is twice in people with 
diabetes. An increase in HbA1C of 1% has a 14% increase in independent risk 
of MI.  
Most common manifestations are: 
1. Acute MI 
2. Angina  
3. Heart failure 
4. Sudden death 
 In Diabetics, during acute phase of MI, there is increased mortality risk 
and  in post infarction period, there is increased risk of morbidity. 
 There is higher incidence of acute coronary events in diabetic patients.  
 Diabetes mellitus is a metabolic disorder in which the rate of 
progression of  atherosclerosis to occlude vessels increases.  
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Even after promptly thrombolysing, the aftermath is worse in Diabetics 
than non-diabetics. There is impaired function of Left ventricle after 
thrombolysis. 
FACTORS ASSOCIATED WITH CAD IN DIABETES: 
TRADITIONAL CARDIAC RISK FACTORS: 
1. Hypertension  
2. Lipid abnormalities  
A. Decreased HDL - C  
B. Increased triglycerides 
C. Presence of oxidized and small dense LDL-C 
3. Obesity 
4. Physical inactivity 
5. Cigarette smoking. 
NON-TRADITIONAL RISK FACTORS: 
1. Microalbuminuria  
2. Homocysteine 
  3. Hemostatic abnormalities 
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A. Factor VIII  
B. vWF 
C. PAI-1 
D. Platelet reactivity 
4. Inflammatory markers  
A. CRP 
B. Fibrinogen 
C. Soluble cell adhesion molecules 
DIABETES SCREENING: 
Early screening and early diagnosis of diabetes have potential values. 
There are a lot of socio economic as well as personal harm because of 
diabetes. 
On diagnosis itself, about 20-30% patients have diabetic complications 
like retinopathy. The estimated time is that even before 5-6 years of diagnosis 
of diabetes, complications begin to develop. So the onset of diabetes is about 
10-12 years before the diagnosis of diabetes is made clinically. 
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HIGH RISK GROUPS: 
1. People with truncal obesity 
2. Siblings or Parents with diabetes mellitus type 2  
3. > 45 years of age 
4. People with CVA, CAD , peripheral vascular disease, hypertension 
5. Dyslipidemia patients 
6. Women with gestational diabetes or macrosomic babies 
7. Obese women with PCOD 
8. Known impaired glucose tolerance or impaired fasting glucose 
It is necessary for early diagnosis and early treatment of diabetes to 
prevent complications. 
A targeted screening programme is necessary to find the high risk 
people. A general health programme at primary health care level is very 
effective. 
The recommended screening test is 2 hour plasma glucose after OGTT.  
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Disadvantages are : 
1. Executional difficulty 
2. Impracticability 
3. Expensive 
People who are screened to have diabetes should undergo a formal 
confirmatory test. 
A large study concluded that diabetes should be considered as an 
equivalent of coronary artery disease. Aggressive management is therefore 
necessary. Asymptomatic hyperglycemia which remains unidentified precedes 
the diagnosis of diabetes. This is the reason why sometimes diabetes is 
diagnosed after the coronary event. 
DIFFERENTIAL DIAGNOSIS OF TYPE 2 DIABETES: 
1. Drug induced hyperglycemia 
2. GDM 
3. Endocrine causes 
4. Latent autoimmune diabetes in adults 
5. Slowly evolving variant of type 1 DM 
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NATURAL HISTORY OF TYPE 2 DM: 
Glucose homeostasis is normally maintained by a balanced interaction 
between insulin sensitivity and secretion. There is defect in both insulin 
secretion and action in Type 2 DM. 
An early feature is insulin resistance. It is genetically determined 
compounded by environmental factors. 
Important sites for insulin resistance are: 
1. Liver 
2. Peripheral tissue 
3. Skeletal muscle 
4. Fat 
INSULIN SECRETION DEFECT: 
 In type 2 diabetes, beta cells are not functioning normally . At the time 
of diagnosis, insulin secretion is already decreased. After about 7-10 years of 
type 2 diabetes, the percentage of patients who need insulin treatment is 60% . 
This is because of the ineffectiveness of oral anti-diabetics by that time. 
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C-peptide is a more stable marker of beta cell reserve than insulin. 
Initially, type 2 diabetics are positive for C-peptide. In response to a challenge 
with secretagogue, the C-peptide levels can be raised above a threshold.  
The plasma insulin levels are high enough in type2 diabetics to prevent 
diabetic ketoacidosis. 
Insulin secretory defect is preceeded by insulin resistance generally. 
Beta cell failure has an inherent component. When there is a progressive 
decline in beta cell secretion, a person progresses from normal to IGT to 
finally type 2 diabetes. 
Some reasons for beta cell failure are: 
1. Glucotoxicity 
2. Amyloid fibril deposition within islet. 
But, all type 2 diabetes cannot be attributed to amyloid fibril deposition. 
Initially, the adaptive capacity of beta cells compensates for insulin resistance.  
At some point in time , insulin secretion reaches a plateau, at this stage , 
there is impaired glucose tolerance. 
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IGT can be reversible by measures such as : 
1. Loss of weight  
2. By increasing physical activity 
3. Drugs which are insulin sensitizing 
Finally, hypoinsulinemia develops. 
DIABETES EFFECT ON ATHEROSCLEROSIS: 
Complex plaques, when disrupt trigger the formation of arterial 
thrombus. Tissue factor plays an important role in extrinsic clotting pathway . 
In the plaque core, it is highly expressed.  
After disruption, Factor VII binds to tissue factor and complexes are 
formed. Finally clotting cascade leads to fibrin formation. In case of insulin 
resistance or diabetic patients, tissue factor is over expressed.  
Plasminogen activator inhibitor 1 is increasingly expressed in diabetics 
which prevents the nascent thrombi dissolution.  
Subclinical plaque burden is increased in diabetics because plaque 
ruptures are more common in them. In diabetic patients, most of the vessels 
such as cerebrovascular, coronary as well as peripheral vessels are involved at  
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an age earlier than non diabetic individuals. The signs and symptoms of 
accelerated atherosclerosis should be considered with great alert by clinicians. 
CORONARY ARTERY DISEASE : 
The incidence of CAD is two times more in diabetic males and four 
times more in post menopausal diabetic females when compared to 
respeective non- diabetics. 
CAD contributes one-third to the death in diabetics after the age of 40. 
It is characrerized by premature age of onset.  
Coronary atherosclerosis in women with diabetes is almost as equal as 
that of diabetic men. But in non diabetic patients, males have a higher 
incidence of CAD than females.  
Premenopausal women who do not have diabetes have a relative 
immunity from CAD mortality. 
Final complications of diabetes such as renal failure, microalbuminuria, 
autonomic neuropathy, foot ulcers and blindness contribute to increased  
Cardiovascular risk.  In diabetics, the incidence and prevalence of triple vessel 
disease is more. The distribution of fibrous plaques is relatively more. 
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It is not yet established whether there is a correlation between severity 
of atherosclerosis in coronary arteries with diabetes duration. Coronary 
atherosclerosis is diffuse in diabetics. 
In diabetic subjects, CAD is characterized by premature onset and 
clinically asymptomatic disease. 75 % of people suffering from acute MI 
before the age of  45 years have glucose intolerance. 
Resting ECG is abnormally documented in about 40% diabetic subjects 
who are ambulant and normotensive. It doubles on exercise testing when 
compared to non diabetics. 
There is greater prevalence of silent myocardial infarction in diabetics. 
One etiology advocated is autonomic neuropathy. But, diabetics who have 
already developed severe form of autonomic neuropathy have suffered from 
painful form of MI. 
RISK FACTORS: 
1. HYPERGLYCEMIA: 
It is an important independent risk for CAD. There is an association 
between hyperglycemia and increased mortality. 
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2.LIPIDS: 
Increased triglycerides, decreased HDL are more commonly seen in 
Type 2 DM. The levels of LDL are not much different from that of non 
diabetics. 
3. INSULIN RESISTANCE: 
It is mostly associated with obesity, increased BP, increased 
triacylglycerol, and decreased HDL, all of which contributes to increased risk 
of CAD. 
4. OBESITY: 
When energy intake exceeds energy expenditure, the excessive body fat 
is stored. This results in obesity. BMI is a frequently used parameter . When 
fat accumulates centrally in upper body areas, there is an increased risk of  
co-morbidities. In this aspect, the waist- hip ratio is a stronger predictor of 
CVD than BMI. 
The mortality rate is increased to 85% when acute MI is associated with 
DKA. Intracoronary streptokinase restores the occluded vessels’ patency in 
two- third diabetics. Coronary angiography can precipitate acute renal failure 
in diabetics who are dehydrated.  
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PRIMARY PREVENTION: 
1. Diet and exercise. 
2. Reduction of weight. 
3. Smoking cessation. 
4. Hyperglycaemia control 
5. Dyslipidemia management 
6. Hypertension control 
Most cost effective and safest modes of modifying vascular risk factors 
are lifestyle measures such as weight reduction and exercise. These lifestyle 
interventions are effective in reducing HbA1C also. Treadmill fitness is 
improved. 
Blood pressue, both systolic as well as diastolic are improved. High 
density cholesterol and triglycerides are also improved. 
Diabetes support and education reduces low density lipoprotein 
cholesterol to a greater extent. 
These life style measures will benefit for both non- diabetic as well as 
diabetic population. 
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SECONDARY PREVENTION: 
1. Beta blockers have a risk of hypoglycemia unawareness. But it’s 
beneficial effect in cardiovascular disease overweighs the risk. 
2. ACE inhibitors are effective in the prevention of acute events. HOPE 
study concludes this. 
3. Diabetics have abnormal platelet activity. Aspirin is beneficial for this. 
In primary prevention also, aspirin is useful. 
4. Statins confer protection from acute coronary events on a long term 
basis. Also used for primary prevention. 
ETIOLOGY: 
The traditional risk factors and the physiologic abnormalities recently 
recognized are attributable to the accelerated atherosclerosis in diabetic 
patients. 
PATHOLOGY: 
CAD will be widespread by the time diabetic patients present to 
medical personnel with cardiac symptoms/ myocardial infarction demanding 
coronary angiography.  
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There is a balance between vasoconstritory and vasodilatory mediators 
of vascular endothelium. Nitric oxide is vasodilatory; endothelin, 
prostaglandins and angiotensin converting enzyme are vasoconstrictory .  
Some other mechanisms are: 
1. Adipose tissue is increased. 
2. hs-CRP level is elevated. 
3. MAP kinase pathway is up regulated. 
4. NF kappa B pathway is also increased. 
In diabetes , there is endothelial dysfunction due to nitric oxide 
underproduction due to hyperglycemia.  There is impairment in vasodilation.  
Through ‘ toll like receptors’ hyperglycemia activates innate immunity 
leading on to leukocytosis. The result is ischemic reperfusion injury and 
atherosclerotic plaque is formed. 
Stenoses are significant in multiple coronary vessels and >= 1 
obstructive lesion can be found in each vessel . Obstruction of left main 
coronary artery is potentially dangerous. It is much more common in diabetic 
patients.  
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Long segment atherosclerotic disease or atherosclerosis involving distal 
arteries are also common. These kind of diffuse disease processes make the  
vessels unsuitable for PCI/ CABG. In this case , anti - ischaemic medications 
are the best treatment modality.  
Collateral vessels develop as a compensatory response to coronary 
artery stenosis . But, in case of diabetic patients , the development of collateral 
vessels is lesser when compared to non-diabetics . So they are more 
vulnerable to ischaemia. 
In diabetics, coronary atherosclerosis involves all kinds of vessels from 
large , medium to small vessels . So, in diabetics even small vessel disease can 
produce ischaemia. 
During exercise or stress periods , because of already present 
endothelial dysfunction in diabetics, the ability of vasodilatation and blood 
flow augmentation are impaired. 
PREVENTION: 
A multifaceted approach is needed to prevent the cardiovascular disease 
in diabetic patients. 
20 
 
Use of aspirin daily is a primary prevention measure for cardiovascular 
disease in diabetics . A  highly effective measure in preventing the 
microvascular complications is maintaining normal blood glucose . This also 
reduces triglycerides. The treatment target is to maintain HbA1C < 7% 
Exercise is an important as well as a neglected aspect which reduces 
cardiac risk in diabetes. Exercise also benefits for control of hyperglycemia, 
dyslipidemia, hypertension and weight. But, recommendations are required 
individually.  
Exercise should be initiated at low levels and the intensity of exercise 
should be increased gradually.  
 Even, non- specific symptoms such as chest tightness/ constriction 
should be considered as equivalent to ischaemic pain and consultations should 
be sought accordingly. 
High intensity regimens should be avoided because these may 
precipitate unrecognized coronary artery disease which will not have classical 
angina symptoms. 
 Individualized glycemia target is very useful and will avoid the adverse 
effects of hypoglycemia in many patients treated for diabetes.  
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Young individuals have usually shorter diabetes duration and have 
lesser complications. In them, an aggressive glycemic control can be 
beneficial.  
 Older patients have longer duration of diabetes, along with more 
number of complications . An aggressive control of blood sugar levels is not 
warranted in these patients.   
ASYMPTOMATIC ISCHEMIA: 
1 in 5 asymptomatic diabetic patients have inducible ischemia. Its 
significance lies in the extent of compromised myocardium. Prior myocardial 
infarction is of particular concern in case of asymptomatic ischemia.  
Subsequent cardiac events are more common in patients with prior 
myocardial infarction. 
After the development of cardiac autonomic neuropathy, heart rate 
variability to deep breathing as well as valsalva maneuvre is diminished.  
Orthostatic hypotension is common in advanced cases. There may be a 
> 15-20 mmHg fall of systolic blood pressure on standing position. 
Any diabetic patient whose ECG shows evidence for ischemia or 
myocardial infarction Q waves or deep inversion of T waves should be 
subjected to exercise testing with perfusion imaging or echo. LBBB in 
22 
 
diabetic patients raises the possibility that prior myocardial infarction could 
have occurred. 
Inducible ischemia screening should be done in asymptomatic patients 
who are diabetics with occlusive disease involving carotid or peripheral 
arteries. ; autonomic neuropathy or microalbuminuria. 
Some of the inducible ischemia predictors are : 
1. Increasing age 
2. Higher cholesterol level 
3. Male gender 
4. Proteinuria 
5. Cardiac autonomic neuropathy 
6. ST/T wave abnormalities on resting ECG. 
Prior identification of asymptomatic cardiac patients improves the care. 
It helps to motivate patients to take additional medications to treat those risk 
factors. Patients can be motivated to stop smoking, reduce weight . Regular 
exercise can be recommended. 
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REVASCULARISATION: 
The clinical history, anatomy of coronaries, medical condition are taken 
into account in making a decision about by what means, a diabetic patient has 
to undergo revascularisation or intervention. 
The highest risk patients are those with acute coronary syndrome or 
ischemic pulmonary edema.  
The option of PCI / CABG are determined by  
1. Number 
2. Location  
3. Morphology 
4. Extent of coronary stenoses. 
PCI with stenting has an important role in treating diabetic coronary 
artery disease patients . It is favourable along with the intensive platelet 
therapy such as glycoprotein II b/ III a inhibitors in ACS setting. 
Diabetics have an increased rate of intimal proliferation following stent 
placement , increasing the risk of stent thrombosis over the subsequent 6 
months period. Biologically coated stents have reduced risk of restenosis 
particularly in diabetics.  
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Factors which favour CABG are: 
1. LMCA stenosis 
2. Severe multivessel disease  
3. Complex calcified lesions. 
Some cases have multivessel disease in those , either PCI / CABG may 
be technically suitable. In these cases , careful analysis should be undertaken 
comparing the benefits and risks of  percutaneous coronary intervention with 
those of coronary artery bypass grafting. 
MYOCARDIAL INFARCTION: 
The occurrence of myocardial infarction in diabetic patients increase 
the risk of complications like : 
1. Heart failure and shock 
2. Post infarct angina 
3. Recurrent MI 
4. Heart block 
5. Atrial arrhythmias 
6. Renal insufficiency 
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The opening of occluded artery by percutaneous coronary intervention 
or thrombolysis in ST elevation diabetic myocardial infarction patients is less 
optimal because of several factors and there is risk of reocclusion.  
DIGAMI study showed that factors which predict mortality are 
previous heart failure, age and glycometabolic state severity on admission ; 
hypertension and previous myocardial infarction are not the predictors . 
These factors are : 
1. Increased plasminogen activator inhibitor I 
2. Increased fibrinogen  
3. Platelet hyperreactivity 
4. Endothelial dysfunction 
CAD is extensive and at the site of rupture of plaque , the tendency for 
thrombosis is more in diabetics . 
The preferred treatment in Diabetic MI patients with ST segment 
elevation is primary PCI. 
 Advantages are : 
1. More effective reperfusion 
2. Definitve information on the extent of disease 
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3.  No haemorrhagic complications. 
              Adjuvant treatment should include antithrombotic drugs with 
clopidogrel and Glycoprotein IIb/and IIIa inhibitors. So, these patients who 
present within 12 hrs of symptoms onset should be ideally considered for 
primary PCI.  
Particular attention should be given in case of heart failure where 
establishing the patency of secure vessel is critical. 
 During primary angioplasty, multivessel disease is often encountered in 
diabetic MI patients. It poses a challenge for management. The culprit vessel 
responsible for infarction must be placed with stent. This is the ideal initial 
treatment. 
 A smaller section of diabetic patients may require urgent CABG in 
case of inaccessible lesion / left MCA disease. 
       After initial revascularisation following acute MI, aggressive medical 
therapy is necessary. 
PLAQUE:   
           A transition can occur catastrophically in lipid laden atherosclerotic 
plaques leading to plaque disruption. Some have a predisposition to 
disruption of plaque. A thrombus results, which occludes flow of blood  
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which can lead to myocardial necrosis if severe and persistent imbalance 
develop between supply of oxygen and demand. 
         Usually complete plaques are associated with an epicardial coronary 
vessel which has total occlusion. These plaques are less complex in a 
vessel not related to STEMI. 
           RED THROMBI WHITE THROMBI 
Made up of RBCs, fibrin, 
platelets,leucocytes 
Platelets , fibrin 
 Certain atherosclerotic plaques overexpress enzymes degrading extra 
cellular matrix . At the site of disruption of plaques, there is abundant 
macrophages which are activated as well as mast cells which produce these 
proteinases. 
     Also, an increased intraluminal pressure, increased vasomotor tone in the 
coronaries, tachycardia and the nutrient vessels distribution, all these 
combined  and produce disruption of plaque at the fibrous cap margin at the 
shoulder regions. 
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ANATOMY OF CORONARIES AND INFARCTION LOCATION 
            During STEMI early hours, when angiographic studies are done, it 
reveals an approximate 90% total occlusion of the vessel related to infarction. 
spontaneous fibrinolysis can cause recanalization by which total occlusion 
diminishes angiographically in the period after MI.  
Thrombolytic therapy and PCI increases the patency of the artery 
related to infarction markedly. 
 When a thrombus superimposes on ruptured plaque, then distal to the 
occluded artery, a transmural necrosis occurs. Whereas total occlusion which 
occurs chronically usually do not cause MI. 
Factors which affect myocardial viability which is present distal to occlusion 
are: 
1. Collateral vessels. 
2. Myocardial metabolism level. 
3. Stenosis in other arteries. 
4. Speed with which the obstruction develops. 
5. Myocardial quantity supplied. 
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5% of  STEMI patients have normal vessels. This can be explained by a 
lysed embolus, platelet aggregate that has occluded transiently  or a severe 
vasospasm of coronary arteries for a prolonged period. 
    A well supported concept is that sudden occlusion by thrombus 
formed by disruption of lipid laden plaques results in STEMI. 
INFARCTION OF THE RIGHT VENTRICLE: 
    Approximately 50% of inferior walls MI are associated with 
RightVentriclular MI. In those with infarction occurring transmurally of the 
inferoposterior wall as well as septum ( posterior portion ), RV infarction 
exclusively occurs. It also occurs with infarction of inferior walls of left 
ventricle and adjacent septal infarction.  
The incidence of isolated RV infarction is only 3% to 5%. The 
frequency of occurrence of RV infarction with total occlusion of right 
coronary artery is less common. 
 Prolonged ischemia  can be sustained by right ventricle and will usually 
have an excellent contractile fraction recovery after reperfusion. 
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INFARCTION OF ATRIUM :  
By using the PR segment elevation or depression as criteria, 10% of 
patients with acute STEMI can have atrial infarction . atrial wall is ruptured, 
mostly in atrial appendages which can lead to formation of thrombus. Atrial 
arrhythmias can occur. 
PRE HOSPITAL MANAGEMENT: 
        The earliest measure is the restoration of blood flow to the zone of 
infarction. Usually the preferred option is PCI, when it is timely available and 
when it can be provided by a experienced personnel. 
     Necessary steps should be taken in the health care system to deliver 
some form of reperfusion therapy to STEMI patients in a timely fashion.  
These include:    
1) educating people about the symptoms of MI  
 2) contacting medical personnel as early as possible  
 3) reaching the destined hospitals in right time.  
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 4) apt emergency protocols in emergency department so that time for 
door  
to reperfusion can be minimised  
 5) ready availability of expert team to deliver reperfusion therapy. 
Decision making is a problem in case of 
1) Older age 
2) Female sex 
3) Black race 
4) Low socio economic status 
5) Low somatic emotional awareness 
6) History of diabetes, angina or both. 
At risk patients should have a heightened level of awareness. 
IN THE EMERGENCY ROOM : 
Triaging is an important initial work to be done to assess patients at 
high risk and those at low risk. 
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Primary tools are : 
1.typical ischemic type of chest pain 
2.initial 12- lead ECG 
ST segment elevation in the initial ECG with ischemic chest pain is a 
powerful indicator of occlusion of coronary artery by thrombus. 
 
    Preference to invasive strategy if 
1. A skilled laboratory available for PCI 
2. High risk patients. 
a. Cardiogenic shock 
b. Killip class >= 3 
3. Contraindications to fibrinolysis 
4. Late presentation. 
5. STEMI diagnosis is in doubt 
 
Immediately assess the patient if he / she has any contraindications for 
fibrinolysis and reperfusion therapy. 
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FIBRINOLYIC THERAPY – CONTRAINDICATIONS IN STEMI: 
RELATIVE: 
 
1. History of poorly controlled hypertension. 
2. Uncontrolled hypertension on presentation. 
3. Prior thrombotic stroke > 3 months . 
4. Prolonged CPR ( >10 min ) or a major surgery ( < 3 weeks ). 
5. Any recent internal bleed. 
6. Bleeding from vascular punctures. 
7. Prior exposure to streptokinase  ( >5 days ago ). 
8. Previous allergic reaction to streptokinase. 
9. Pregnancy 
10. Peptic ulcer – active 
11. Current anticoagulants use. 
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ABSOLUTE: 
 
1. Prior ICH 
2. AV malformation 
3. Intracranial malignancy 
4. Thrombotic stroke within 3 months except within  3 hr 
5. Aortic dissection  
6. Bleeding diathesis or any active bleed (except menses) 
     7.Significant trauma to head / face within 3 monts 
 
 
In STEMI patients, lethal arrhythmias occur suddenly, so all STEMI 
patients should have an intravenous access as well as bedside ECG monitor. 
SOME BENCHMARKS ARE : 
1. A door to needle time <= 30 mins. 
2.  A door to balloon time <= 90 mins. 
It should be restated as 
1. EMS to needle time <=30 mins. 
2. EMS to balloon time <= 90 mins. 
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MEASURES OF  GENERAL TREATMENT : 
 Aspirin : 
         It is used for primary prevention of cardiovascular events as well as for 
the entire spectrum of ACS. It also form an important part of initial 
management suspected STEMI patients. Dose  162 to325 mg . Chewing is 
better than swallowing  for absorption. 
FOR CONTROL OF ISCHEMIC PAIN : 
           One of the aim of treatment is to relieve pain. Underdosage should be 
avoided for initial control of pain. Some drugs used are nitrates, morphine, o2, 
beta blockers. 
ANALGESICS : 
                      Expect  in case of hypersensitivity, the drug of choice is 
morphine.  
Dose 4 to 8 mg i.v, repeat the doses of 2 to 8 mg at 5 to 15 minutes 
interval till pain subsides ( or ) toxicity develops. 
                    Consequently, metabolic demands of heart are reduced. It also 
reduces pulmonary edema. 
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         Hypotension is a problem with administration of morphine, which can 
be treated with keeping the lower extremities of the patient elevated. Atropine 
can be given for hypotension and bradycardia. Respiratory depression can 
occur for which naloxone is used for treatment. For nausea and vomiting, 
phenothiazine can be given. 
 BETA – BLOCKERS : 
- Ischemic pain is relieved 
   Exclude patients with 
1. Heart failure 
2. Hypotension 
3. Bradycardia 
4. I – degree AV block. 
CARDIOVASCULAR DISEASE SCREENING IN DIABETES: 
A screening method for early CAD detection must be 
1. Simple 
2. Widely available 
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3. Cost effective 
4. Applicable to most of the diabetic patients 
Diabetes by itself is a cardiovascular disease equivalent. It is 
challenging to identify high risk people within the population at earliest stage, 
so that adverse events can be prevented by interventions meaningfully. 
In case of diabetic patients presenting with atypical symptoms of 
coronary artery disease , high index of suspicion is necessary. Some of the 
evidence based strategies used in diabetic patients are : 
CARDIOVASCULAR RISK SCORES: 
A few multivariate risk scores are : 
1. UKPDS risk engine 
2. Diabetes audit and research 
3. Hong kong diabetes registry for CAD. 
But, none have universal applicability. Framingham risk score relies on 
age heavily and underestimates the cardiovascular risk in Indians and in 
young people. 
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APPROACH BASED ON RISK FACTOR: 
Various cardiovascular risk factors are : 
1. Dyslipidemia 
2. Hypertension 
3. Obesity 
Higher risk of cardiovascular disease is associated with greater number 
of risk factors. Several prospective intervention studies have shown that 
reduction of risk factors aggressively is a strategy very effective for reducing 
primary as well as secondary risk. This approach is recommended in the 
guidelines for managing diabetic patients to reduce cardiovascular risk. 
RESTING ECG: 
This provides important clues to prior myocardial infarction 
1. Pathological Q waves 
2. T wave inversion 
3. LBBB 
Non-specific ST/T changes can be predictors of ischemia inducible on 
stress testing. 
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MICROALBUMINURIA: 
Overt nephropathy has a high risk of cardiovascular events and diabetic  
patients with this condition  should ideally be screened for CAD.  
HOPE trial shows that the risk of myocardial infarction and stroke are 
significantly increased even in patients with mild renal insufficiency. 
In patients having Type 2 diabetes as well as chronic kidney disease , 
about 40% experience a cardiac event within 5 years . Microalbuminuria 
powerfully predicts risk of cardiovascular events. It is a useful test of risk in 
the future. 
COMPLICATIONS INVOLVING MICRO AND MACROVESSELS: 
Complications like neuropathy and retinopathy are risk predictors of 
coronary artery disease. 
Clinical manifestations of autonomic neuropathy are: 
1. Unexplained tachycardia 
2.Orthostatic hypotension  
3.Hypertension 
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These are  also CAD risk factors . Screening for this condition is 
recommended by American Diabetes Association in all diabetic patients.  
Other indicators of CAD are: 
1. Peripheral neuropathy 
2. Transient ischemic attack 
3. Stroke 
EXERCISE CAPACITY AND AGE: 
When exercise capacity is impaired , it carries an adverse prognosis ; 
obese diabetics have a high risk of cardiac disease. 
Advanced age is a powerful risk factor of cardiovascular events in 
diabetics. Diabetics  of age 65 years or more are highly likely to have positive 
stress test. 
HYPERGLYCEMIA: 
It is a well known predictor of microvascular complications and 
atherosclerosis also. Hyperglycemia which is chronic and untreated is an 
important risk factor for cardiovascular disease . 
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SOME NEWER MODALITIES: 
1.Cardiac CT 
2.Cardiac MRI 
3.Carotid intima media thickness ( CIMT) 
4.Arterial stiffness 
5.Brachial artery FMD 
1. CARDIAC CT: 
The burden of atherosclerosis is determined non-invasively by cardiac 
CT. 
Calcium scoring in the coronaries using CT scan is an important measurement 
of atherosclerosis extent. 
Radiation and cost are two important parameters that limit the use of 
cardiac CT.  
2. CARDIAC MRI has similar use but, there is no risk of radiation exposure. 
3. CIMT is a reliable echocardiography based measurement which correlates 
better with atherosclerosis extent. Left main disease is even predicted by 
CIMT. 
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4. Flow mediated Dilation is a simple tool used in bedside to detect 
dysfunction of endothelium . Vasodilatory response mediated by endothelium 
in response to increased blood flow is measured. By occluding the artery first, 
flow is increased and ischemia is produced. It is followed by release. 
5. Arterial stiffness assessment measures vessel wall function . Intima media 
thickness measures the structure of vessel wall. Non- invasive measurement of 
arterial stiffness is possible and pulse wave velocity can be recorded.   
Arterial stiffness correlates well with age which is a conventional risk 
factor for CAD.  
Unknown diabetes patient can be identified by Indian diabetes  Risk 
Score with which arterial stiffness correlates well . Pulse wave velocity is an 
emerging tool as a early marker of CAD. 
Peripheral arterial disease can be screened in the bedside by simple 
measuring of ankle brachial index. Impaired ABI is a CVD risk marker. A 
value less than 0.9 has an increased mortality risk. 
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C-REACTIVE PROTEIN: 
A powerful inflammatory marker is hs-CRP . It is an independent  
predictor of diabetes and cardiovascular disease. Conventional risk factors if 
absent, this is a useful marker of risk of cardiovascular disease.  
Excess  fat in the body as  well as subcutaneously , and physical 
inactivity are important reasons for high levels of this parameter in the 
population . But there are no prospective studies on the large scale to show 
that hs-CRP can be definitely used as a biomarker for cardiovascular risk in 
diabetics. 
 ECG CHANGES IN MYOCARDIAL INFARCTION: 
MI evolves through three recognizable phases: 
1.Hyperacute, 
2..Fully evolved , 
3..Chronic stabilized 
HYPERACUTE PHASE: 
With in a few hours of infarction , this phase occurs . It is one of the 
frequently un recognized or ignored phase in literature. 
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Four principal manifestations are : 
1.Ventricular activation time is increased. 
2. R wave amplitude is increased. 
3. ST segment is elevated. 
4. T waves are tall and widened. 
In the leads facing uninjured surface, reciprocal changes occur . An 
identical presentation can be seen in the hyperacute phase of prinzmetal 
angina. But, there is a resolution of changes within 20 minutes. 
Primary ventricular fibrillation is an important complication during this 
phase. There is a need for vigilant monitoring during this phase.  
FULLY EVOLVED PHASE: 
1.QS complex represents myocardial necrosis. 
2. ST segment is convex upward which represents myocardial injury. 
3. Inverted , symmetrical T wave represents myocardial ischemia. 
MYOCARDIAL NECROSIS: 
QRS negativity or positivity loss reflects loss of myocardium. 
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Early and complete reperfusion of myocardium is the main aim behind  
thrombolysis. There is elevated risk of complications after incomplete or also  
failed thrombolysis. 
 In STEMI, ST segment resolution following fibrinolysis, assessed on 
ECG is a cost effective measure of assessing reperfusion of coronary vessels. 
The outcome depends on microvascular flow , for which resolution of ST 
segment is a better reflector. Coronary angiogram can not assess myocardial 
microvascular reperfusion. 
 Schroeder et al had reported that the most important early mortality 
predictor is the absence of resolution of ST segment. We can also identify 
patients for PCI at the earliest. So, ECG is the cheapest and an effective tool 
to assesss reperfusion. 
 In diabetics, failed reperfusion is more than complete reperfusion 
whereas complete reperfusion is more in non diabetics. The occurrence of 
complications is also more following thrombolysis in diabetics than non 
diabetics.  
Recurrent ischemic pain is more common in diabetic patients because 
of more residual lesion in the artery related to infarction. 
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Heart failure and arrythmias are also more common in diabetic 
myocardial infarction patients. 
THROMBOLYTIC THERAPY   VS  PCI :  
Failure of reperfusion in diabetics is mainly because of increased 
aggregation of  platelets, reduced vasodilation which is endothelium mediated. 
Thrombogenicity is enhanced and fibrinolysis is impaired. So, PCI is a 
better option in diabetic myocardial infarction patients. 
 So, attention  must be directed to the above mentioned factors by 
secondary preventive measures like adequate control of glycaemic status and 
lowering of lipid levels. 
 Derangements in metabolism occur at the time of infarction. This leads 
to anaerobic metabolism of glucose and a shift towards utilisation of free fatty 
acids. This affects both non-ischaemic and ischaemic areas. Infarct size is 
increased. The viable myocardial tissue has a compensatory response which is 
reduced. 
 Therapy with Insulin in acute MI counteracts the above said adverse 
effects. The pro thrombotic state is also improved. 
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THROMBOLYTIC THERAPY: 
 During acute MI, a well recognized and effective treatment is 
intravenous streptokinase. This has mortality benefits on cardiovascular 
events. The ongoing infarction process is interrupted and there is also reversal 
of metabolic derangements of viable cells. 
STRESS HYPERGLYCEMIA: 
 There is a detrimental effect of stress hyperglycemia on the outcome of 
thrombolysis. This entity can be differentiaated only after acute phase with 
certainty. 
 Compared to non-diabetics, the use of thrombolysis is less frequent in 
diabetics. The reason is the less frequent presentation of ST elevation in ECG 
of diabetic patients.  
CLINICAL PRESENTATION: 
 In diabetic patients , ischaemic chest pain may be absent or blunted. In 
Framingham Heart study, unrecognized MIs account for 25% . 
 
 
48 
 
 In non diabetics, silent infarctions account for 22%. In diabetics, it is 
39%. It is mainly because of autonomic neuropathy in diabetic patients. 
 Usually , atypical symptoms like dyspnoea, vomiting, confusion, 
fatigue may lead to delay in diagnosing acute MI in diabetics. These may lead 
to increase in cardiac mortality and morbidity. 
STEMI patients are in considerable distress whereas angina patients 
often remain still because activity increases pain. In LV failure , patients 
appear pale and propped up. Bradycardia or tachycardia can occur. 
More specific cardiac markers are now available which help in the 
diagnosis of MI very accurately. But, the treatment should not be delayed for 
the results to come. This is because of the golden period of reperfusion 
therapy. 
STEMI: 
STEMI naturally occurs in early morning hours because of circadian 
variation of various endogenous factors. Clinically silent episodes of 
infarction occur because of adequate collaterals. 
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Complete occlusion of an artery by thrombus produces myocardial 
injury transmurally and leads to STEMI. Acute coronary events presenting 
without ST elevation in ECG are diagnosed as UA / STEMI 
STEMI patients are the ideal candidates for reperfusion therapy. 
UA/STEMI patients should not receive pharmacologic reperfusion therapy but 
are treated with anti thrombotics and later by PCI. 
All patients of ACS must receive therapy with anti platelets and anti 
coagulants. 
Factors contributing to increased occurrence of cardiovascular problems in 
diabetes are: 
1. Atherosclerotic process is accelerated. 
2. A specific form of cardiomyopathy develops. 
3. Microvessel disease. 
4. Autonomic neuropathy develops. 
SMALL VESSEL DISEASE: 
Occlusion of smaller vessels is the hallmark in the heart disease due to 
diabetes. The resultant ischemia leads to interstitial fibrosis resulting in  
 
50 
 
impaired LV function. The chest pain due to small vessel disease lasts longer 
than classical angina .  
When it involves the smaller supplying sino atrial or atrio ventricular 
node , syncope , arrhythmias, conduction blocks and also sudden death can 
occur. 
DIABETIC CARDIOMYOPATHY: 
It is myocardial derangement with abscence of atherosclerosis in 
coronaries. It is a functional disturbance . In the myocardium which surrounds 
the small intramural vessels , there is increased accumulation of connective 
tissue . This diffuse myocardial fibrosis is analogous to the micro infarcts 
present in DR. 
Saccular aneurysms can occur in arterioles in any layer of myocardium. 
Due to accumulation of glycoprotein , ventricular wall becomes less 
complaint . Response to catecholamines is diminished and calcium uptake is 
reduced .  
Glucose is the source of energy for contraction of myocardium . The 
accumulation of substances which are osmotically active like fructose and 
sorbitol extracellularly impedes oxygen supply and by way , the underlying 
ischemia due to microvessel disease is accentuated. 
51 
 
 
 
Very early changes of diabetic cardiomyopathy in ECG are ST/ T wave 
changes . In insulin resistance states , there is hyperinsulinemia which has a 
growth promoting effect on the ventricular septum.  
A very sensitive index for LV dysfunction is systolic time interval. Pre 
ejection period / Left ventricular ejection time  ( PEP / LVET  ) value 
increases   in diabetic subjects and correlate with increased blood glucose 
values. LV relaxation is also prolonged . Diastolic dysfunction , that is due to 
relaxation failure , is a predictor for morbidity and mortality. 
In diabetic subjects , congestive cardiac failure can ocur with a 
relatively normal size cardiac chambers . It is presumed that , small 
myocardial infarcts occur frequently which can result in scarring and fibrosis 
leading to diminished distensibility of ventricles.  
HEART FAILURE:  
It is more common in diabetic subjects leading on to increased mortality 
. They have a poor prognosis , mainly due to underlying cardiomyopathy .  In 
diabetic men , heart failure is twice more common . In diabetic women , it is 
five times more common than the non- diabetics . 
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 The aim of treating the patients is to decrease mortality . This is 
achieved by slowing down the remodelling process . By using drugs that 
inhibit Renin Angiotensin System  and  Sympathetic Nervous System , the 
remodelling process can be attenuated. 
ACUTE CORONARY SYNDROME IN DIABETES: 
About 20 to 30 percent of patients who are hospitalized during acute MI 
are found to have hyperglycemia. 
Usually , diabetic myocardial infarction patients are younger in age , 
have greater mortality risk , face major complications .  
DIGAMI study states that glycemic control during acute MI should be 
achieved intensively . This shifts the use of free fatty acids to glycolysis for 
the generation of ATP. 
The sulfonylurea receptor expressed in cardiac muscle is SUR 2A ; in 
vascular smooth muscle , it is SUR 2B . Some sulfonylureas ( except 
gliclazide) have benzamido group. The ischemic preconditioning is interferred 
by these sulfonyl ureas. Ischemic preconditioning is also obviated by 
hyperglycemia. 
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For one year following acute coronary event, aspirin and clopidogrel 
should be given in combination. After one year , one of the two drugs should 
be continued . In TRITON TIMI trial, prasugrel has been found to have an 
increased efficacy.    
In non-ST elevation MI , Low molecular weight  heparin is better than 
Unfractionated heparin , because the former has more stability , predictable 
anticoagulation , side effects are lesser , administration is easy and also cost 
effective . 
In OASIS 6 study, Fondaparinux , a selective inhibitor of Factor Xa, 
has been found to be superior when compared to unfractionated heparin . In 
OASIS 5 study , it is found to be equally effective and the bleeding is less 
when compared to enoxaparin .  
Hemorrhagic complications are an important cause of failure in the 
treatment of acute coronary events. This property of lesser bleeding with 
Fondaparinux is very useful in this acute coronary syndrome setting. But in 
the setting of PCI for AMI , Fondaparinux alone has an increased risk of 
catheter thrombosis . So, additional heparin is needed in case of PCI. 
Thrombolysis in diabetic myocardial infarction patients is less effective 
when compared to non- diabetic counterparts. 
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tPA is superior to streptokinase for thrombolysis in case of survival 
benefit and quality of reperfusion. Also antibody formation is not there with 
use of tPA . But since it is costly, streptokinase is mainly used as a 
thrombolytic agent in most centers.  
PCI in diabetics  is  complicated . Because the disease is extensive , can 
involve small branches , and risk of re-stenosis is more , drug eluting stents 
are found to have lesser restenosis with the complication of late stent 
thrombosis. By dual anti-platelet therapy, this complication can be managed in 
the long term effectively. CABG is superior to PCI in  diabetic MI patients. 
STREPTOKINASE: 
Dr. William Smith Tillett discovered streptokinase , the first 
thrombolytic agent.  
Fibrinogen is present in plasma , but absent in serum. This fibrinogen is 
the reason for agglutination of streptococci. As the fibrinogen is used for 
agglutination of streptokinase , the plasma is devoid of fibrinogen.  
Streptokinase produced by streptococci causes lysis of clot. A lytic 
factor is normally present in plasma in an inactive form. Streptococcal 
fibrinogen activates this lytic factor which then lyses the fibrin clot. 
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 This fibrinolysin is termed as streptokinase. The inactive lytic factor is 
plasminogen and its active enzyme is plasmin.   
The concept of golden hour in acute myocardial infarction management 
emerged from the fact that when more than few hours have passed between 
thrombosis and thrombolysis, heart muscle will die and could not be saved. So 
, earlier the thrombolysis , the smaller the area of infarction. 
GISSI trial established a significant difference in the rates of mortality 
between the SK and non-SK group at 12 months , SK is especially useful in 
the 0-3 and 3-6 groups. 
EPICARDIAL REPERFUSION: 
The major etiology for MI is coronary atherosclerosis . At the 
ischemia onset , biochemical as well as functional abnormalities begin  
immediately . Myocardial contractility is lost severely within 60 seconds. 
After at least 20-40 min of total occlusion , irreversible injury occurs .  
Early reperfusion limits the progression of sub-endocardial infarct  to 
transmural infarct. This transmural infarct is linked to remodelling of ventricle 
and survival rate is decreased. 
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So , the recommended door to balloon time is less than 90 monutes in 
hospitals capable of PCI, door to needle time is less than 30 min for 
thrombolytic administration in hospitals where PCI facility is not available. 
MEASURES OF EPICARDIAL REPERFUSION : 
TIMI FLOW: 
Based on  the assessment of contrast opacification rate of the infarct 
related artery  visually,  a grading scale is developed for coronary blood flow. 
TIMI flow grade 3 has reduced morbidity as well as mortality than grades 0,1 
or 2.   
CHEST PAIN RESOLUTION: 
Resolution of ischemic chest pain due to coronary reperfusion is 
associated with thrombolysis or PCI. But this criteria has several limitations . 
This indicator is not reliable for successful reperfusion.  
It  has false positive values that 13%  patients relieved of chest pain still 
have occluded artery.  Persistant chest pain is asssociated with TIMI grade 2 
but not total occlusion .  
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ST SEGMENT  RESOLUTION  IN ECG : 
Maroko et al first analysed the efficacy of this non invasive tool in 
thrombolytic therapy in AMI.  
>= 70 % resolution is complete ; 30 % - 70 % is partial and <=30% is 
failed or no ST resolution . Incomplete resolution has a 10 times more risk of 
mortality than complete resolution. 
ST resolution is a better variable than myocardial blush in prognosis. 
With regard to availability and simplicity , ST segment resolution is a very 
useful tool for assessing the efficacy of thrombolytic therapy. 
Schroder et al 
ST SEGMENT RESOLUTION MORTALITY AFTER 180 MIN 
Complete  2.2% 
Partial 3.4% 
Failed 8.8% 
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SERUM MYOGLOBIN: 
Its measurement has limitations similar to ST resolution.  
Since individual measures are inadequate in predicting the success of 
reperfusion, for identifying candidates for rescue PCI, a combined criteria is 
used. 
 
COMBINED CRITERIA: 
1. <= 50% ST resolution at 90 minutes 
2. Persistant chest pain at the time of angiography 
3. A ratio smaller than 4 of serum myoglobin at 60 minutes / baseline 
  
 
REPERFUSION STRATEGIES: 
Total ischemic time is defined as the symptom onset time to the time to 
reperfusion therapy initiation time. So the concept of reperfusion is to 
minimize this ischemic time. 
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PCI :  
In a hospital capable of doing PCI , STEMI patients should ideally be 
treated with primary PCI within 90 minutes of contact with first medical 
personnel. 
FIBRINOLYSIS: 
In a hospital not capable of doing PCI or in conditions , the patients 
could not be transferred to a PCI capable center, within 30 minutes of 
presentation , the fibrinolyic therapy should be given. 
FACILITATED PCI: 
After full dose fibrinolytic therapy, facilitated PCI is associated with 
increased rate of vessel closure and death because following fibrinolysis, there 
is an early prothrombotic condition. So , this may be considered in regimens 
using other than full dose streptokinase therapy. 
In case of failed fibrinolysis, rescue PCI can be undertaken. Survival 
benefits are demonstrated with rescue PCI for patients in cardiogenic shock, 
congestive cardiac failure or  arrhythmias. 
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PHARMACOINVASIVE APPROACH: 
PCI is done 4-6 hours after pharmacological fibrinolysis. This has a 
lower risk of bleeding .TRANSFER -AMI trial has shown 30 day mortality 
reduction with this approach. 
MYOCARDIAL INFARCTION: 
DIGAMI study shows that factors which predict mortality are previous 
heart failure, age, and glycometabolic state severity on admission and 
previous myocardial infarction. 
The risk of heart failure is increased in diabetic MI patients because of 
impaired infarction induced remodelling as well as decompensation by 
metabolic derangement. 
Stress hyperglycemia also increases the risk of mortality as well as 
heart failure and shock. 
From enzyme release and angiographic studies , it is evident that 
thrombus in the coronary artery of diabetic patients is more resistant to 
therapy with thrombolysis. 
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GUSTO study showed similar 90 min patency rate in diabetic and non-
diabetic  subjects. No evidence to state that hemorrhagic complications are 
more in diabetic than non diabetic subjects. 
ECG IN MYOCARDIAL INFARCTION: 
1.QS complex 
2.Qr complex 
3.R wave amplitude loss 
Hyperacute phase: 
Increased R wave amplitude: 
The R wave in the corresponding leads become, indeed very tall .  
Extensive anterior – V1 – V6 
Anteroseptal  -  V1-V3 
Anterolateral – V4-V6, I , aVL 
Antero apical – V5, V6 
Inferior – II, III, aVF 
Inferolateral – II , III, aVF, I, aVL 
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Inferoanterior – II, III, aVF, V1, V2 
Lateral – I , aVL 
Posterior – V1, V2 
Anterior – extensive with LBBB. 
  Subendocardial without Q wave 
These changes occur because of acute injury block. The injuried tissue 
conducts current at a slower rate and is still not necrosed. 
Ventricular Activation Time  increased: 
Onset of intrinsicoid deflection is delayed ; leaning of R wave to the 
right of observer. 
ST segment  – slope elevation: 
There is loss of concave upward nature of ST segment. First it becomes 
straightened, then it becomes elevated resembling a slope elevation. The 
proximal limb of the T wave and this straight ST segment blends. ST segment 
straightening can be an earliest sign also. 
T waves – tall and widened 
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LOCALIZATION OF TERRITORY : 
Always towards the site of ischemia, the ST segment is deviated . 
Pathology involving anterior wall causes elevation of ST segment in leads in 
the anterior precordium . That involving inferior wall causes changes on III, 
aVF, II.  
Infarction in right ventricle causes elevation of ST segment in right 
precordial lead V1. In case of involvement of first septal perforator, lead V1 ‘s 
ST segment is elevated. 
LAD lesion: 
ST segment deviation is present in leads I, aVL, V3-V6 in case of 
anterior MI, occasionally lead II . In inferior leads III, aVF, reciprocal changes 
are present. 
 ST  segment changes in V1 are less frequent than in V2 / V3 in anterior 
MI. In case of acute anterior MI , when there is ST  elevation in V1 also , it 
implies that the conal branch is absent/ small enough to reach to 
interventricular septum . Conal branch is usually a branch of Right coronary 
artery. 
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Elevation of ST segment in aVL and III with positive T waves implies 
that there is wrap around  LAD around the  apex and is occluded. 
Three main areas supplied by LAD : 
1) Basoseptal by first septal branches. 
2) Lateral basal by first diagonal branches 
3) Infero apical by distal LAD 
Occlusion of left main coronary artery:  
          When ST elevation is present in all leads except inferior leads, this 
lesion should be suspected. When RBBB is associated with  posterobasal 
ischemia signs, this occlusion should be suspected. 
  When aVR has greater ST elevation than V1 , left main coronary artery 
occlusion should be suspected. 
RCA occlusion / LCX occlusion: 
In leads II, III, aVF , also sometimes in leads V5, V6, there is elevation 
of ST segment. In lead I, aVL, reciprocal ST depression  is present sometimes 
in V2, V3, when the ST segment depression in V2, V3. 
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When the  ST segment depression in V1, a reciprocal change is not 
present, instead there is elevation, Right ventricular  myocardial infarction 
should be suspected. But ST depression  in V1 indicates also posterior wall 
MI. 
In case of occlusion of Right coronary artery , elevation of ST segment 
in lead III is more than lead II and there is depression of ST segment in lead I.  
 In left circumflex artery  occlusion, there is ST elevation in II, III, aVF, 
as well as in V5, V6 (or) I and aVL. 
INDICATIONS FOR THROMBOLYSIS BASED ON ECG CHANGES: 
 Evidence of ST elevation of >0.1 mV in two limb leads or two or more  
precordial leads which are anatomically contiguous indicates there is acute MI 
and emergent thrombolysis can be instituted. 
Recanalization is paralleled by ST segment regression. Incomplete 
damage also predicts mortality. Extensive myocardial damage is suggested by 
ST segment re elevation. 
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In acute coronary syndrome , the most lethal form is STEMI . Here , the 
artery is completely occluded by thrombus, the territory supplied , suffers total 
cessation of blood supply and the ECG shows ST elevation . New Q waves  
typically evolve in 70 % patients. 
Only based on ECG alone, STEMI is not diagnosed.  Two out of 
following three elements are necessary: 
1.  > 30 mins of ischemic chest pain. 
2. In serial ECG there is evolutionary changes. 
3. Because of myonecrosis, the serum cardiac biomarkers rise and then 
fall. 
It is of paramount importance to accurately diagnose STEMI. 
MI COMPLICATIONS: 
ACUTE COMPLICATIONS: 
1. Arrhythmias 
2. Sudden death 
3. Cardiogenic shock 
4. Fibrinous pericarditis 
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5. Infarct extension 
6. Mural thrombi 
7. Embolization 
8. Cardiac rupture 
 
ARRHYTHMIAS: 
After acute MI , 90% patients at sometime develop, rhythm 
abnormality. 
Reason for tachyarrhythmias are: 
1. Reperfusion 
2. Altered tone of autonomic nervous system 
3. Hemodynamic instability 
Tachyarrhythmias associated with increased mortality are:  
1) Premature ventricular complexes – subacute and late 
2) Late onset non sustained ventricular tachycardia 
3) Monomorphic VT – sustained 
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Initially, arrhythmias evolve from the ischemic zone surrounding the 
infarcted myocardium because of metabolic abnormalities, later these result 
from scar tissue which surround viable tissues. 
Within 24 hours, cardiac conduction disturbances is experienced by 
25% patients . In inferior wall  MI, bradyarrhythmias developing within 24 
hours are usually benign. But those occurring later than 24 hours needs to be 
monitored carefully and treated. 
In case of anterior wall MI, there is higher mortality rate associated 
with conduction disturbances such as left anterior hemiblock  and right bundle 
branch block . The occurrence of Atrial Fibrillation is only 5 to 10% 
CARDIOGENIC SHOCK : 
 When there is atleast 40% loss of  left ventricular  mass, cardiogenic 
shock follows MI. This constitutes  about  44%  of  short term deaths. 
MYOCARDIAL RUPTURE: 
An early catastrophic and fatal event is rupture of free wall of LV. 
Hemodynamic collapse occurs . A late complication is aneurysmal dilatation. 
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VENTRICULAR SEPTAL RUPTURE: 
Delayed or failed thrombolysis is associated with ventricular septal 
rupture. 
MITRAL REGURGITATION: 
Mechanisms are: 
1. Severe LV dilatation 
2. Papillary muscle dysfunction due to IWMI 
3. Papillary muscle infarction 
DRESSLER SYNDROME: 
More common in anterior wall STEMI. With thrombolysis , it’s 
incidence has been decreased.  
LIFE STYLE MODIFICATIONS AFTER ACS: 
Cardiac rehabilitation programme should be implemented. 
1. Mediterranean type of diet is advisable. 
2. Moderation of alcohol drinking 
3. Physical activity 
4. Smoking cessation  
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5. Weight reduction 
6. Hypertension control 
7. Glycemic control. 
ST segment resolution : 
It is advantageous to monitor ST segment resolution continuously. 
Finding ST segment resolution at some point in time after fibrinolysis 
helps to identify patients for resue PCI. 
Non invasive diagnosis of  failed thrombolysis: 
1) Chest pain – non resolution 
2) Non resolution of ST elevation at 90 mins after thrombolysis 
3) Post/pre thrombolysis enzyme levels 
< 5 at 1 hour 
< 10 at 11/2 hour. 
In case of failed thrombolysis, the following options can be tried. 
1. With a newer agent, repeat thrombolysis can be tried. 
2. Abciximab, tirofiban or either GP II b / III a inhibitors 
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3..Intra-aortic balloon counter-pulsation 
4.Rescue PCI 
5.PCI and GP IIb / IIIa combination. 
Coronary branches which are clinically important are: 
1. LCA   A. Anterior descending 
           B. Circumflex 
2. RCA  A. Right main coronary artery 
           B. Posterior descending artery 
The biochemical changes which occur in acutely ischemic myocardium are : 
1. Anaerobic glycolysis 
2. Inadequate ATP production 
3. Lactic acid accumulation 
4. Mitochondrial glycogen depletion and swelling 
These changes are early and reversible. 
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In Indians the CAD risk factors are : 
1. Lipoprotein (a) 
2. High LDL 
3. Low HDL 
4. Hypertension 
5. Diabetes 
6. Tobacco 
7. Hyperhomocysteinemia 
There are four mechanism of angina : 
1. Primary angina : due to coronary vasospasm as in Prinzmetal angina. 
2. Secondary angina : exertional angina mainly due to increased 
demand  
3. Mixed form 
4. Syndrome X : with normal coronaries, there is angina but there is a 
positive threadmill test. 
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Silent Myocardial ischemia -Prevelance : 
1. In asymptomatic middle aged men 2-4 % 
2. In asymptomatic post MI 20-30 % 
3. Angina 80 – 90% 
4. MI – 25 % 
Reasons are :  
1. Pain system is defective : 
a. Elderly patients with dementia or stroke 
b. Pain threshold is high 
c. Autonomic changes at receptor level 
d. Neuropathy eg. Alcohol, DM. 
2. Collateral vessels protective effect. 
3. There is denervation of pain pathway in the previous myocardial scar 
4. Denervation surgically after CABG. 
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 Evolution of infarction : 
1. Irreversible damage of myocardium follows longer periods of  ischemia 
2. An advancing wave front of necrosis develops in the territory supplied 
by the infarct related artery. 
3. Collaterals when effective / fibroinolysis endogenously can delay 
damage to myocardium. 
4. During the early 6 hours , the myocardium is destined to die 
5. Restoration of patency of coronary artery completely as early as 
possible is the effective way to prevent long – term damage. 
Four types of MI : 
I --- primary coronary event is the reason 
II ---secondary to ischemia due to imbalance. 
III --sudden cardiac death 
IV -- iatrogenic   
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1. PCI      
2. Verified thrombosis of stent  
3. CABG. 
 ST elevation but no ischemia : 
1. Early repolarisation 
2. LVH  / LBBB 
3. Brugada syndrome 
4. Hyperkalemia 
Chest pain but no ischemia: 
1. Myocarditis 
2. Pericarditis 
3. Acute aortic dissection 
4. Pulmonary embolism 
5. Costochondritis 
6. Gastro-oesophageal disorders 
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 Various thrombolytic agents: 
Fibrin-non specific: 
1. Streptokinase. 
2. Anisolated  plasminogen streptokinase activator complex 
3. Urokinase 
4. Arvin 
Fibrin specific: 
1. Staphylokinase 
2. Recombinant single chain urokinase 
3. rtPA / alteplase 
4. Reteplase 
 Indications for their use are: 
1. Acute myocardial infarction 
2. Pulmonary thromboembolism 
3. Acute ischemic stroke 
77 
 
 
 
4. Deep venous thrombosis 
5. Acute peripheral arterial occlusion 
Also used in: 
                                   1.cardiac arrest 
       2.Thrombosis of prosthetic heart valves 
       3.Sub acute and late stent related thrombosis 
       4. loculated pericardial effusions 
       5.thrombus in right atrium 
       6.cerebral sinus thrombus 
An ideal thrombolytic should be 
1. Specific to thrombus 
2. Act rapidly 
3. Efficacy should be high 
4. Side effects low 
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5. Low incidence of rescue procedures, reocclusion 
6.  Easy administration 
7. Cost effective 
8.  Long term effects should be good 
Early thrombolytic therapy has the following advantages:  
1. Patency of occluded artery is restored early 
2. Infarct size is limited 
3. LV fuction is preserved 
4. Mortality and morbidity are decreased 
Complications associated with streptokinase: 
1. Hypotension 
2. Reperfusion arrhythmia 
3. Allergic risks 
4. Major / minor bleeding. 
ACS AND GIK INFUSION: 
 During ischemia , cardioprotection due to Glucose Insulin Potassium 
infusion is due to reduction in free fatty acids. High levels of free fatty acids 
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has been associated with higher incidence of ventricular fibrillation in early 
phases. 
 Glycolytic flux is increased and the development of contractures due to 
ischemia is reduced. Reperfusion injury is decreased  and post infarction 
myocardial contractility   is improved. FFA induced biochemical 
abnormalities are reduced by normalising intramitochondrial energy 
production. Final outcome is reduction in infarct size .This helps to increase 
myocardial salvage and thereby improve clinical outcomes. 
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    MATERIALS AND METHODS 
 
STUDY POPULATION: 
This study was conducted among 100 patients , admitted in coronary 
care unit with the diagnosis of ST elevation myocardial infarction. Out of 100, 
60 are diabetics and 40 are non-diabetics. 60 males and 40 females are 
studied. Among males, 40 are diabetics and 20 are non-diabetics; among 
females 20 are diabetics and 20 are non-diabetics. 
INCLUSION CRITERIA: 
1. Patients with STEMI coming to hospital within 12 hours of chest 
pain 
2. Known diabetic or newly diagnosed during  hospital stay 
3. Non-diabetics 
EXCLUSION CRITERIA: 
1. Patients presenting late after 12 hours of chest pain 
2. Type 1 diabetics 
3. Patients with impaired glucose tolerance 
4. Patients with history of previous MI. 
5. Patients with only stress hyperglycemia on admission. 
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ANTICIPATED OUTCOME: 
         Successful thrombolysis with streptokinase (> 70% ST segment 
resolution)  is significantly more in non-diabetics when compared to  
diabetics, whereas failed thrombolysis (< 30% ST segment resolution)  is 
significantly more in diabetics than non-diabetics.    
DATA COLLECTION: 
• Detailed Clinical History , 
• Detailed Clinical Examination , 
 Random blood sugar values are obtained on admission. 
• Electrocardiogram obtained on admission and 90 min after 
streptokinase infusion. 
• Fasting and post prandial glucose values are recorded from all patients , 
in the morning of day following admission, or once the patients are 
stable. 
LABORATORY INVESTIGATIONS: 
• Electrocardiogram obtained on admission and 90 min after 
streptokinase infusion. 
• Random, fasting and post-prandial (2 hr ) blood glucose are 
obtained. 
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STUDY PROTOCOL: 
 Patients who are diagnosed with ST elevation myocardial infarction are 
included in the study. 
 Random blood sugar values are obtained on admission. 
 Electrocardiogram obtained on admission and 90 min after 
streptokinase infusion. 
 Fasting and post prandial glucose values are recorded from all patients , 
in the morning of day following admission, or once the patients are 
stable. 
 The results are then analysed. 
DESIGN OF STUDY: 
  Prospective interventional study  
PERIOD OF STUDY: 
April 2014 to August 2014 
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COLLABORATING DEPARTMENTS: 
Department of General Medicine, 
Department of Cardiology, 
Department of Biochemistry. 
ETHICAL CLEARANCE: 
The study was approved by the ethical committee of Govt. Rajaji 
Hospital, Madurai. 
CONSENT: 
Individual written and informed consent from patient andor 
attendant. 
ANALYSIS: 
Statistical analysis 
CONFLICT OF INTEREST: 
Nil 
FINANCIAL SUPPORT: 
Nil 
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RESULTS AND INTERPRETATIONS: 
TABLE 1: ST SEGMENT RESOLUTION IN STUDY POPULATION 
 
 
 
 
FAILED 
RESOLUTION 
<30% 
 
PARTIAL 
RESOLUTION 
30-70% 
 
COMPLETE 
RESOLUTION 
>70% 
 
P 
VALUE 
DIABETIC 
(60) 
40(67%) 9(15%) 11(18%) 0.001 
NON 
DIABETIC 
(40) 
7(17.5%) 12(30%) 21(52.5%) 0.038 
TOTAL (100) 47 21 32  
‘P’ VALUE 0.004  0.020  
 
On comparing the ST segment resolution among Diabetic and non-
diabetic myocardial infarction patients , by using Chi square test, it is found 
that failed thrombolysis (<30% resolution ) is more in diabetics than non-
diabetics ( p value is 0.004) which is significant whereas successful 
thrombolysis (>70% resolution) is more in non-diabetics than diabetics ( p 
value is 0.020; significant). 
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In diabetic MI patients( n=60), the number of people with successful 
thrombolysis( >70% ST resolution ) is 11 (18%), whereas failed thrombolysis 
( < 30% ST resolution ) is 40 (67%). p value is 0.001, which is significant. 
 In non-diabetic MI patients (n=40), the number of people with 
successful thrombolysis ( >70% ST resolution) is 21 (52%), whereas failed 
thrombolysis ( <30% ST resolution ) is 7 ( 17.5%) . p value is 0.038 which is 
also significant. 
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TABLE 2 : AGE CHART 
 
 
AGE GROUP (IN YEARS) 
 
% OF STUDY POPULATION 
31-40 1 
41-50 19 
51-60 44 
61-70 32 
71-80 4 
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TABLE 3 : GENDER CHART 
 
 MALE FEMALE 
DIABETIC 40 20 
NON-DIABETIC 20 20 
 
 
  In the study population, (n=100), number of diabetics is 60, in which males  
40 ; females  20. Number of non diabetics is 40 in which males 20 and 
females 20.  
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TABLE 4: LOCATION OF MI 
 
DIABETIC STATUS/ 
LOCATION OF MI 
DIABETIC NON-DIABETIC 
ANTEROSEPTAL 7 9 
ANTERIOR WALL 35 17 
INFERIOR WALL 18 14 
    
 
 
Among the location of MI, anterior wall constitutes majority in both diabetic 
and non diabetic groups. Inferior wall comes second and anteroseptal 
constitutes the least 
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TABLE 5: ST RESOLUTION IN SUB CATEGORIES- SEX AND 
DIABETIC STATUS 
 
 COMPLETE 
RESOLUTION 
PARTIAL 
RESOLUTION 
FAILED 
RESOLUTION 
DIABETIC 
MALES(N=40) 
10(25%) 6(15%) 24(60%) 
DIABETIC 
FEMALES(N=20) 
3(15%) 2(10%) 15(75%) 
 
Among diabetics subjects (n=60), 40 are males and 20 are females. 
Among diabetic males, 60% had failed resolution, 15 % had partial resolution 
and 25% had successful resolution. Among diabetic females, 75% had failed 
resolution, 10% had partial resolution, 15 % had successful resolution. 
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DIABETICS: 
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TABLE 6 : ST RESOLUTION IN SUB CATEGORIES- SEX AND 
DIABETIC STATUS 
 
  
COMPLETE 
RESOLUTION 
 
PARTIAL 
RESOLUTION 
 
FAILED 
RESOLUTION 
NON DIABETIC 
MALES(N=20) 
11(55%) 6(30%) 3(15%) 
NON DIABETIC 
FEMALES(N=20) 
10(50%) 6(30%) 4(20%) 
 
Among non-diabetics subjects (n=40), 20 are males and 20 are females. 
Among non -diabetic males,  55% had complete resolution, 30% had partial 
resolution and only 15% had failed resolution. Among non-diabetic females, 
50% had complete resolution, 30 % had partial resolution and only 20 % had 
failed resolution.  
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NON-DIABETICS: 
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DISCUSSION: 
 A well recognized ,effective treatment during acute myocadial 
infarction is I.V. Streptokinase. For cardiovascular mortality , it has beneficial 
effect. Early and successful reperfusion is the aim of thrombolysis. When the 
reperfusion is incomplete, left ventricular disfunction occurs and the risk of 
mortality is increased. 
The ongoing process of infarction as well as the metabolic derangement 
(due to ischemia) of the remaining viable cells must be reversed . 
Serial monitoring of the reperfusion status , using ECG is an ideal 
method and is also cost effective. It tells much about the myocardial perfusion 
than epicardial perfusion . in fact, myocardial perfusion is a better factor 
which should be established at an earliest time, so that myocardial death can 
be prevented. 
Various risk factors contribute to coronary heart disease. 
Hyperglycemia is an important major contributor for accentuation of coronary 
atherosclerosis. 
As assessed by previous studies, the efficacy of thrombolytic therapy is 
established beyond doubt, both angiographically as well as 
electrocardiographically. 
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The main purpose of this study is to showthat diabetes as an 
independent factor affects the thrombolytic outcome after STEMI . this 
assessed with the help of ECG as a simple tool. The thrombolytic efficacy of 
streptokinase is also assessed by this study.  
In patients without diabetes , efficacy is good ; it means that success 
rate of thrombolysis is more; failure rate is only less. But, in a diabetic patient 
presenting with STEMI , who are thrombolysed with streptokinase , because 
of presence of unfavourable , as well as extensive plaque pathology, the 
efficacy is poor ; that is , failure rate is more. So , PCI may be a better option 
for diabetes presenting with Myocardial Infarction. 
Since there is an extensive disease involving vessels at multiple levels 
or involving multiple vessels, it is also found in many studies that CABG 
would be a better option finally for diabetic myocardial infarction patients. 
In diagnosing diabetes for the first time after presentation, stress 
hyperglycemia should be excluded. Most patients have elevated blood sugar 
levels at initial presentation with myocardial infarction because of stress 
induced factors. Once the patients’s condition has stabilised or at a time 
before discharge, the diagnosis of diabetes mellitus should be made. 
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Initially , this stress induced hyperglycemia has deterimental effect to 
the patient. Various studies have confirmed the efficacy of GIK (glucose 
insulin with potassium) infusion for treatment of stress hyperglycemia.  
Over the past decades, because of aggressive control of risk factors, 
cardiovascular events have reduced. Life style modifications, diet plan are 
important aspects in management of risk factors. Finally , a multi-factorial 
approach is needed to reduce chronic cardiovascular complications. 
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CONCLUSION: 
1. On comparing the thrombolytic effect of Streptokinase  , it is observed  that 
failed thrombolysis (< 30% ST resolution )  is more in diabetic STEMI  
patients when compared to non-diabetic STEMI patients. 
2. Successful thrombolysis (>70% ST resolution ) is more in non-diabetic than 
diabetic STEMI patients.  
3. Among diabetics, failed thrombolysis ( 67%) is more than successful 
thrombolysis ( 18%). 
4. Among non-diabetics, successful thrombolysis (52.5%) is more than failed 
thrombolysis ( 17.5%). 
So, the outcome of thrombolysis of  acute ST elevation myocardial 
infarction patients is affected by type 2 diabetes mellitus . In diabetic ST 
elevation myocardial infarction  patients , Percutaneous coronary intervention 
can be a better option than thrombolysis. ( Arch Intern Med 2007; 167(13)). 
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LIMITATIONS: 
1. The time period from the onset of chest pain to the time of 
thrombolysis , that is the total ischemic time, is  not take into 
account. 
2. The efficacy of other newer thrombolytic agents needed to be tested.  
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PROFORMA 
 
Name   :  Age/Sex:        Occupation: 
I.P. no   : 
Address   : 
Date of admission  :                                                                        
Date of discharge  : 
Presenting complaints: 
H/o chest pain, breathlessness, sweating, palpitation, giddiness, etc 
Past history: 
 History of Diabetes mellitus, previous MI. 
Clinical examination: 
General examination: 
Consciousness, dyspnoea, diaphoresis, Pallor, cyanosis  
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Vitals:  
Pulse Rate, Blood pressure, Respiratory Rate, SpO2, temperature. 
Systemic examination:  
CVS, RS, abdomen and CNS 
Laboratory investigations: 
Random, fasting and post-prandial glucose 
Electrocardiogram 
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ABBREVIATIONS: 
MI- myocardial infarction 
ACS- acute coronary syndrome 
ECG- electrocardiogram 
HDL-C- high density lipoprotein cholesterol 
LDL-C- low density lipoprotein cholesterol 
IGT- impaired glucose tolerance 
CVD- cardiovascular disease 
PCI- percutaneous coronary intervention 
CABG- coronary artery bypass graft 
vWF- von willebrand factor 
PAI-1-plasminogen activator inhibitor-1 
CRP- c-reactive protein 
CVA- cerebrovascular accident 
CAD- coronary artery disease 
PCOD- polycystic ovarian disease 
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OGTT- oral glucose tolerance test 
HbA1C- hemoglobin A1C 
LBBB- left bundle branch block 
LMCA- left main coronary artery 
LCX- left circumflex  
RCA- right coronary artery 
LAD- left anterior descending 
UA- unstable angina 
STEMI- ST elevation myocardial infarction 
DR- diabetic retinopathy 
CPR- cardiopulmonary resuscitation 
AV- atrioventricular 
RVMI- right ventricular myocardial infarction 
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MASTER CHART 
S.No NAME AGE/ SEX MI 
DM 
DURATION 
(IN YRS) 
RBS FBS PPBS INITIAL STE 90 MIN % RESOLUTION RESULT 
1 Balakrishnan 50/M IW 2 218 183 312 4 3.5 12.5 F 
2 Natarajan 61/M AW 2 208 135 203 26.5 20 24 F 
3 Murugan 60/M AW 1 180 102 152 17 5 71 S 
4 Masanam 74/M AW 1 198 115 260 10.5 5 52 P 
5 Murugesan  60/M AW 4 156 104 160 17 7.5 16 F 
6 Jeevagan 34/M AW 0 202 180 246 7 4 42 P 
7 Paulraj 60/M IW 2 212 92 236 7 2 71 S 
8 Ravi 48/M IW 3 192 126 220 15 5 66 P 
9 Mookan 49/M AS 4 148 105 188 21 3 85 S 
10 Thangaraj 45/M AW 7 219 150 242 24 2 12.5 F 
11 Lakshmanan 51/M IW 5 189 162 248 22.5 17.5 22 F 
12 Ponnaiah 53/M AW 3.5 232 198 270 26 16 23 F 
13 Kannan 44/M IW 2 162 130 206 25 6 76 S 
14 Ravikumar 48/M IW 8 191 152 289 20.5 15 26 F 
15 Ramu 56/M IW 0 204 130 219 28 20.5 27 F 
16 Arumugam 51/M AW 6 179 118 252 14 3 78 S 
17 Munusamy 55/M AW 10 210 190 280 13 10 23 F 
18 Chandran 70/M AS 20 194 126 241 27 20 25 F 
19 Saravanan 65/M AW 8 168 108 211 16 6 62 P 
20 Saleem 62/M AW 3 169 128 258 12 10 17 F 
21 Satheesh 59/M IW 4 212 176 235 16.5 12 27 F 
22 Gurusamy 75/M AW 11 200 155 218 20 5 75 S 
23 Palani 51/M AW 0 230 192 270 14 10 28 F 
24 Rajan 56/M AW 2.5 206 175 225 23 18 22 F 
25 Kannan 60/M IW 9 186 162 210 15 12 20 F 
26 Karuppaiah 48/M AW 6.5 224 140 260 28 23.5 16 F 
27 Mani 54/M AS 7 245 135 282 7 4 42 P 
28 Jeevan 64/M AW 3 216 150 248 16 12.5 22 F 
29 Karuppan 65/M IW 5 149 102 202 22 6 72 S 
30 Palpandi 71/M AW 8 196 146 213 17 12 29 F 
31 Ibrahim 47/M AW 0 225 165 246 27 24 11 F 
32 Muthupandi 54/M IW 4 260 190 289 13 11 15 F 
33 Velmani 42/M AW 3 182 100 205 12 7 41 P 
34 Mari 57/M IW 3 198 169 240 28 8 71 S 
35 Muniappan 44/M AW 5 221 159 210 19 16.5 13 F 
36 Sheik 50/M AW 5.5 209 121 269 22 18 18 F 
37 Joseph 63/M AS 7 252 153 288 18 15 71 F 
38 Gowtham 55/M AW 1 193 140 211 7 5 28 F 
39 Senthil 66/M AW 3 215 180 260 26 22 15 F 
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S.No NAME AGE/ SEX MI 
DM 
DURATION 
(IN YRS) 
RBS FBS PPBS INITIAL STE 90 MIN % RESOLUTION RESULT 
40 Marimuthu 60/M AW 6 232 163 249 15 12 20 F 
41 Padma 53/F AS 0 205 104 210 14 7 50 P 
42 Muniammal 58/F IW 6.5 189 135 214 18.5 15.5 16 F 
43 Panchu 56/F AW 9 242 172 251 12 8.5 29 F 
44 Revathi 68/F AW 18 202 149 213 19.5 17 12 F 
45 Chandra 62/F IW 4 198 132 216 26 7 73 S 
46 Karuppayee 60/F AW 5.5 276 195 290 14 10.5 25 F 
47 Rakku  70/F AW 12 212 156 249 9 7 22 F 
48 Vasantha 54/F IW 0 195 160 269 15 13 13 F 
49 Princemary 56/F AW 7 182 159 270 15 12 20 F 
50 Subetha 59/F AW 8 250 149 285 18 11 38 P 
51 Kala 72/F IW 11.5 280 192 302 28 25 10 F 
52 Petchi 66/F AS 14 195 139 252 14 4 71 S 
53 Palaniammal 61/F IW 5 280 179 310 25.5 21 18 F 
54 Ramayee 59/F AW 0 196 155 240 18 15 17 F 
55 Kalaivani 64/F AW 9 260 170 298 10 7.5 25 F 
56 Lurthubegam 61/F IW 7 212 160 240 21 5 76 S 
57 Rani 57/F AW 3 230 149 220 30 27 10 F 
58 Lakshmi 69/F AW 9 186 130 205 14.5 11.5 21 F 
59 Allirani 57/F AS 5 259 282 314 7.5 5.5 26 F 
60 Ramathilagam 52/F AW 6 257 220 399 17 10.5 40 P 
61 Elango 54/M IW 0 135 70 1322 25 7 72 S 
62 Murugaiyan 48/M AW 0 112 85 136 13.5 7.5 44 P 
63 Alagarsamy 50/M AW 0 105 89 120 19 9 53 P 
64 Balu 70/M IW 0 140 97 109 15 3.5 77 S 
65 Arokiadoss 66/M AS 0 129 79 113 21 18 14 F 
66 Chellaiya 65/M AW 0 109 89 119 12 3 75 S 
67 Muthu 61/M AW 0 131 93 124 23 15 35 P 
68 Sundar 64/M IW 0 123 73 115 16.5 4.5 72 S 
69 Murugapandi 48/M AW 0 109 79 102 16.5 4 76 S 
70 Kannan 50/M AW 0 96 89 109 22.5 3 87 S 
71 Rafeeq 56/M IW 0 150 83 105 14 10.5 25 F 
72 Velu 63/M AS 0 119 74 112 12.5 3.5 72 S 
73 Prabhakaran 54/M AW 0 106 79 115 26 14.5 44 P 
74 Mookan 51/M AW 0 115 93 108 23 6.5 72 S 
75 Thangam 46/M IW 0 139 90 105 15 12 20 F 
76 Kumar 57/M AS 0 145 86 111 29 4 86 S 
77 Muniyandi 55/M AW 0 121 75 119 12.5 3.5 72 S 
78 Ramani 52/M IW 0 116 71 136 13 6.5 50 P 
79 Selvam 67/M IW 0 102 74 129 11.5 3.5 70 S 
80 Mahalingam 65/M AS 0 98 86 09 19 10.5 45 P 
81 Muthupechi 59/F AS 0 98 78 121 18 5.5 69 P 
82 Vadivu 55/F AW 0 103 69 105 27 5 81 S 
83 Amutha 60/F IW 0 133 73 111 16 13 19 F 
84 Pavithra 63/F AW 0 129 89 125 27.5 24 13 F 
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S.No NAME AGE/ SEX MI 
DM 
DURATION 
(IN YRS) 
RBS FBS PPBS INITIAL STE 90 MIN % RESOLUTION RESULT 
85 Rajammal 49/F IW 0 116 67 115 23.5 3.5 85 S 
86 Chellammal 54/F AS 0 109 73 113 12.5 6 52 P 
87 Priya 58/F IW 0 131 79 119 18.5 9 51 P 
88 Rasiyabegam 68/F AW 0 145 84 124 22 6 73 S 
89 Jansi 48/F AW 0 107 89 124 9 2.5 72 S 
90 Christy 54/F AS 0 111 81 119 14 10 28 F 
91 Jamela 62/F IW 0 123 94 117 19.5 5 74 S 
92 Tamilselvi 69/F IW 0 130 74 129 26 13 50 P 
93 Mookammal 64/F AW 0 125 77 136 25 3.5 86 S 
94 Muneeswari 52/F AS 0 115 70 120 7 5 28 F 
95 Rajathi 61/F AW 0 107 92 133 13 3.5 73 S 
96 Shanthi 47/F IW 0 118 94 129 15.5 8 48 P 
97 Vasantha 58/F IW 0 128 84 130 20 4 80 S 
98 Lalitha 63/F AW 0 124 88 129 13.5 3 78 S 
99 Leela 56/F AS 0 129 79 130 22 9.5 57 P 
100 Gandhimathi 70/F AW 0 140 80 116 11.5 2.5 78 S 
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